|
ZNF182 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.168130E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.223700E-03 |
| Normal-vs-Stage2 |
7.060000E-02 |
| Normal-vs-Stage3 |
1.196820E-01 |
| Normal-vs-Stage4 |
3.052800E-01 |
| Stage1-vs-Stage2 |
3.913000E-01 |
| Stage1-vs-Stage3 |
8.728600E-01 |
| Stage1-vs-Stage4 |
7.240800E-01 |
| Stage2-vs-Stage3 |
3.923800E-01 |
| Stage2-vs-Stage4 |
8.384800E-01 |
| Stage3-vs-Stage4 |
6.942800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.54760000000388E-05 |
| Normal-vs-AfricanAmerican |
3.157600E-02 |
| Normal-vs-Asian |
3.023800E-01 |
| Caucasian-vs-AfricanAmerican |
4.125600E-01 |
| Caucasian-vs-Asian |
9.674000E-01 |
| AfricanAmerican-vs-Asian |
7.646000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.613900E-04 |
| Normal-vs-Female |
1.564020E-04 |
| Male-vs-Female |
1.299800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.222100E-02 |
| Normal-vs-Extreme_Weight |
1.441730E-02 |
| Normal-vs-Obese |
1.299730E-03 |
| Normal-vs-Extreme_Obese |
2.338200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.804800E-01 |
| Normal_Weight-vs-Obese |
4.476000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.568600E-01 |
| Extreme_Weight-vs-Obese |
1.871830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.205400E-01 |
| Obese-vs-Extreme_Obese |
3.584000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.504400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.11430000002433E-06 |
| Normal-vs-Age(61-80Yrs) |
1.171770E-02 |
| Normal-vs-Age(81-100Yrs) |
8.310000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.688400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.168200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.889600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.488280E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.902400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.507400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.75559999995956E-06 |
| Normal-VS-Type2 PRCC |
9.746200E-01 |
| Normal-VS-KIRP CIMP |
3.531600E-02 |
| Normal-VS-Unclassified PRCC |
2.544600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.78079999999525E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.912800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.241600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.702620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.101300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.379400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.123370E-01 |
| Normal-vs-N1 |
1.194100E-02 |
| Normal-vs-N2 |
4.054000E-01 |
| N0-vs-N1 |
8.165600E-02 |
| N0-vs-N2 |
9.956800E-01 |
| N1-vs-N2 |
4.402000E-01 |
|
|
